| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 345.88B | 320.71B | 316.75B | 435.32B | 398.62B |
| Gross Profit | 313.81B | 320.71B | 316.75B | 234.68B | 272.47B |
| EBITDA | 95.68B | 0.00 | 0.00 | 102.78B | 90.49B |
| Net Income | 85.14B | 86.48B | 86.27B | 85.22B | 76.17B |
Balance Sheet | |||||
| Total Assets | 18.69T | 17.08T | 15.73T | 14.07T | 12.59T |
| Cash, Cash Equivalents and Short-Term Investments | 1.32T | 1.96T | 1.83T | 1.73T | 1.57T |
| Total Debt | 929.67B | 251.20B | 270.41B | 111.76B | 91.11B |
| Total Liabilities | 17.68T | 16.05T | 14.77T | 13.24T | 11.79T |
| Stockholders Equity | 1.01T | 1.03T | 954.87B | 824.23B | 794.09B |
Cash Flow | |||||
| Free Cash Flow | 88.21B | 376.93B | 250.37B | 462.51B | 95.70B |
| Operating Cash Flow | 101.62B | 397.28B | 263.34B | 474.91B | 109.56B |
| Investing Cash Flow | -1.17T | -480.40B | -242.43B | -511.51B | -182.92B |
| Financing Cash Flow | 1.34T | -30.78B | 1.43T | -37.74B | 52.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.17T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
71 Outperform | HK$462.45B | 10.39 | 11.77% | 5.80% | 1.90% | 12.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | HK$506.25B | 5.02 | 9.01% | 5.76% | -5.46% | 0.33% | |
57 Neutral | HK$649.95B | 6.72 | 9.30% | 5.37% | -1.54% | -3.95% | |
57 Neutral | HK$210.57B | 5.64 | 6.61% | 5.53% | -8.41% | -5.52% | |
52 Neutral | HK$182.90B | 5.60 | 4.68% | 9.09% | -7.28% | -5.00% |